← Back to guidelines
Cardiology121 papers

Metabolic dysfunction-associated steatotic liver

Last edited: 4/15/2026

Overview

Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses conditions characterized by hepatic steatosis often linked to metabolic disturbances, including choline deficiency syndrome (CDS) influenced by estrogen regulation of PEMT activity 1.

Diagnosis

  • Elevated liver enzymes, particularly ALT and AST 3.
  • Presence of conjugated bilirubin in blood tests 3.
  • Imaging studies (ultrasound, MRI) showing hepatic steatosis 3.
  • Genetic testing for PEMT polymorphisms (e.g., rs12325817) in women to assess risk for CDS 1.
  • Management

  • Dietary choline supplementation for identified deficiencies 1.
  • Discontinuation of causative medications (e.g., captopril if cholestatic jaundice suspected) 2.
  • Management of underlying conditions like shock, heart failure, and infections 3.
  • Supportive care including monitoring liver function tests 3.
  • Special Populations

  • Premenopausal Women: Genetic predisposition to PEMT dysregulation may affect susceptibility to choline deficiency-related liver dysfunction 1.
  • Postmenopausal Women and Men: Higher risk for developing multiorgan dysfunction due to lack of protective estrogen effects 1.
  • Key Recommendations

  • Screen premenopausal women with risk factors for PEMT gene polymorphisms to identify susceptibility to choline deficiency syndrome (Evidence: Moderate 1).
  • Discontinue suspected medications like captopril if cholestatic jaundice develops post-administration (Evidence: Weak 2).
  • Manage postoperative intrahepatic cholestasis by addressing contributing factors such as fluid overload and infections, alongside supportive care (Evidence: Expert opinion 3).
  • References

    1 Resseguie ME, da Costa KA, Galanko JA, Patel M, Davis IJ, Zeisel SH. Aberrant estrogen regulation of PEMT results in choline deficiency-associated liver dysfunction. The Journal of biological chemistry 2011. link 2 Tabibian N, Alpert L, Alpert E. Captopril-induced liver dysfunction. Southern medical journal 1987. link 3 Hampel N, Lichtig C, Gersh I, Gellei B. Postoperative intrahepatic cholestasis. International surgery 1977. link

    Original source

    1. [1]
      Aberrant estrogen regulation of PEMT results in choline deficiency-associated liver dysfunction.Resseguie ME, da Costa KA, Galanko JA, Patel M, Davis IJ, Zeisel SH The Journal of biological chemistry (2011)
    2. [2]
      Captopril-induced liver dysfunction.Tabibian N, Alpert L, Alpert E Southern medical journal (1987)
    3. [3]
      Postoperative intrahepatic cholestasis.Hampel N, Lichtig C, Gersh I, Gellei B International surgery (1977)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG